scholarly journals Gadolinium Neutron Capture Therapy (GdNCT) Agents from Molecular to Nano: Current Status and Perspectives

ACS Omega ◽  
2022 ◽  
Author(s):  
Son Long Ho ◽  
Huan Yue ◽  
Tirusew Tegafaw ◽  
Mohammad Yaseen Ahmad ◽  
Shuwen Liu ◽  
...  
Keyword(s):  
Neutron Capture ◽  
Current Status ◽  
Neutron Capture Therapy

scholarly journals Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects

2005 ◽  
Vol 11 (11) ◽  
pp. 3987-4002 ◽  
Author(s):  
Rolf F. Barth ◽  
Jeffrey A. Coderre ◽  
M. Graça H. Vicente ◽  
Thomas E. Blue
Keyword(s):  
Boron Neutron Capture Therapy ◽  
Neutron Capture ◽  
Current Status ◽  
Neutron Capture Therapy ◽  
Future Prospects ◽  
Boron Neutron Capture

scholarly journals Cover Image: Boron neutron capture therapy: Current status and future perspectives

2020 ◽  
Vol 40 (9) ◽  
Author(s):  
Mayya Alexandrovna Dymova ◽  
Sergey Yurjevich Taskaev ◽  
Vladimir Alexandrovich Richter ◽  
Elena Vladimirovna Kuligina
Keyword(s):  
Boron Neutron Capture Therapy ◽  
Neutron Capture ◽  
Cover Image ◽  
Current Status ◽  
Neutron Capture Therapy ◽  
Future Perspectives ◽  
Boron Neutron Capture

scholarly journals Boron neutron capture therapy: Current status and future perspectives

2020 ◽  
Vol 40 (9) ◽  
pp. 406-421 ◽  
Author(s):  
Mayya Alexandrovna Dymova ◽  
Sergey Yurjevich Taskaev ◽  
Vladimir Alexandrovich Richter ◽  
Elena Vladimirovna Kuligina
Keyword(s):  
Boron Neutron Capture Therapy ◽  
Neutron Capture ◽  
Current Status ◽  
Neutron Capture Therapy ◽  
Future Perspectives ◽  
Boron Neutron Capture

The Current Status and Perspectives of Delivery Strategy for Boronbased Drugs

2019 ◽  
Vol 26 (26) ◽  
pp. 5019-5035 ◽  
Author(s):  
Zhu Yinghuai ◽  
Xinglong Lin ◽  
Hongming Xie ◽  
Jianlin Li ◽  
Narayan S. Hosmane ◽  
...  
Keyword(s):  
Neutron Capture ◽  
Cell Walls ◽  
Current Status ◽  
Neutron Capture Therapy ◽  
Natural Occurrence ◽  
Pharmaceutical Drugs ◽  
Delivery Strategy ◽  
Boron Neutron Capture ◽  
Trade Name ◽  
Advanced Development

Boron-containing compounds are essential micronutrients for animals and plants despite their low-level natural occurrence. They can strengthen the cell walls of the plants and they play important role in supporting bone health. However, surprisingly, boron-containing compounds are seldom found in pharmaceutical drugs. In fact, there are no inherent disadvantages reported so far in terms of the incorporation of boron into medicines. Indeed, drugs based on boron-containing compounds, such as tavaborole (marked name Kerydin) and bortezomib (trade name Velcade) have been investigated and they are used in clinical treatment. In addition, following the advanced development of boron neutron capture therapy and a new emerging proton boron fusion therapy, more boron-containing medicinals are to be expected. This review discusses the current status and perspectives of delivery strategy for boron-containing drugs.

Sign in / Sign up

Export Citation Format

Share Document